Trial Profile
A Phase IIa Study of Z-207 in Patients with Seasonal Allegic Rhinitis - Investigation of the Efficacy and Safety of Z-207 after Single Injection -
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 May 2016
Price :
$35
*
At a glance
- Drugs Z 207 (Primary)
- Indications Allergic rhinitis
- Focus Therapeutic Use
- Sponsors Zeria
- 24 May 2016 New trial record